Epcoritamab in R/R B-Cell NHL
Phase I/II Trial of CD3 x CD20 Bispecific Antibody Epcoritamab (GEN3013) in R/R B-Cell NHL

Released: June 05, 2020

Activity

Progress
1
Course Completed